Immunotherapy has been a transformational advancement in cancer care, but not all patients benefit from it. A significant ...

An AI model applied to pathology slides accurately predicts immunotherapy response in patients with metastatic non-small cell ...

A new study found zero relapses among patients given a new treatment regime, with far better results than would be expected ...

New findings of an Alliance Foundation Trials study show combining immunotherapy and chemotherapy before surgery improves ...

A new study suggests that a urine-based biomarker test shows promise in forecasting bladder cancer treatment response, which ...

AI chatbots may suggest unsafe cancer treatment alternatives, risking patient health by promoting misinformation instead of ...

Patients who developed myocarditis within the first month of receiving immune checkpoint inhibitor therapy were more likely ...

Pancreatic tumors reprogram immune cells that normally shut down tumor-killing cells, according to a team at Oregon Health & ...

Injecting nivolumab (Opdivo) directly into precancerous oral lesions led to reduction in lesion size and allowed some patients to avoid surgery, according to research from a phase I clinical trial ...

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industrial chain, announced that a recent clinical case report on its self-developed novel Nectin-4 ADC ...

Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced that the first patient has been successfully dosed in a phase Ⅱ clinical study evaluating ...

A biology-guided artificial intelligence model applied to routine pathology slides accurately predicted outcomes and response to immunotherapy in patients with metastatic non-small cell lung ...